e-learning
resources
London 2016
Sunday, 04.09.2016
Airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Monitoring oxidative stress during recovery from COPD exacerbations: Comparison of airway and systemic malondialdehyde levels
Orsolya Drozdovszky (Budapest, Hungary), Orsolya Drozdovszky, Imre Barta, Zsuzsanna Kelemen, Janos Varga, Balazs Antus
Source:
International Congress 2016 – Airway biomarkers
Session:
Airway biomarkers
Session type:
Thematic Poster
Number:
1059
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Orsolya Drozdovszky (Budapest, Hungary), Orsolya Drozdovszky, Imre Barta, Zsuzsanna Kelemen, Janos Varga, Balazs Antus. Monitoring oxidative stress during recovery from COPD exacerbations: Comparison of airway and systemic malondialdehyde levels. Eur Respir J 2016; 48: Suppl. 60, 1059
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Assessment of malondialdehyde in the airways during treatment of COPD exacerbations
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Monitoring catalase activity in COPD exacerbations
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Monitoring oxidative stress in the lung: Changes in superoxide dismutase (SOD) activity during the course of acute exacerbations in COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Malondialdehyde level in chronic obstructive pulmonary disease exacerbations
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Endothelial dysfunction and systemic inflammation during acute exacerbations of COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Nitrosative and oxidative stress in virus-induced COPD exacerbations
Source: Annual Congress 2013 –Viral infections
Year: 2013
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
The effect of pulmonary rehabilitation on oxidative stress after acute exacerbation in COPD
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Relationship of blood eosinophil count to exacerbations in COPD
Source: International Congress 2016 – Airway response to infection
Year: 2016
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Cachexia in patients with acute COPD exacerbations: relationship to pulmonary function, systemic inflammation and oxidative stress
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008
Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
Cells biomarkers of bronchial brush-biopsies at COPD exacerbation
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept